Cargando…

No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome

PURPOSE: The benefit from attenuation and scatter correction (ASC) of dopamine transporter (DAT)-SPECT for the detection of nigrostriatal degeneration in clinical routine is still a matter of debate. The current study evaluated the impact of ASC on visual interpretation and semi-quantitative analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Schiebler, Tassilo, Apostolova, Ivayla, Mathies, Franziska Lara, Lange, Catharina, Klutmann, Susanne, Buchert, Ralph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541531/
https://www.ncbi.nlm.nih.gov/pubmed/37328621
http://dx.doi.org/10.1007/s00259-023-06293-2
_version_ 1785113921432059904
author Schiebler, Tassilo
Apostolova, Ivayla
Mathies, Franziska Lara
Lange, Catharina
Klutmann, Susanne
Buchert, Ralph
author_facet Schiebler, Tassilo
Apostolova, Ivayla
Mathies, Franziska Lara
Lange, Catharina
Klutmann, Susanne
Buchert, Ralph
author_sort Schiebler, Tassilo
collection PubMed
description PURPOSE: The benefit from attenuation and scatter correction (ASC) of dopamine transporter (DAT)-SPECT for the detection of nigrostriatal degeneration in clinical routine is still a matter of debate. The current study evaluated the impact of ASC on visual interpretation and semi-quantitative analysis of DAT-SPECT in a large patient sample. METHODS: One thousand seven hundred forty consecutive DAT-SPECT with (123)I-FP-CIT from clinical routine were included retrospectively. SPECT images were reconstructed iteratively without and with ASC. Attenuation correction was based on uniform attenuation maps, scatter correction on simulation. All SPECT images were categorized with respect to the presence versus the absence of Parkinson-typical reduction of striatal (123)I-FP-CIT uptake by three independent readers. Image reading was performed twice to assess intra-reader variability. The specific (123)I-FP-CIT binding ratio (SBR) was used for automatic categorization, separately with and without ASC. RESULTS: The mean proportion of cases with discrepant categorization by the same reader between the two reading sessions was practically the same without and with ASC, about 2.2%. The proportion of DAT-SPECT with discrepant categorization without versus with ASC by the same reader was 1.66% ± 0.50% (1.09–1.95%), not exceeding the benchmark of 2.2% from intra-reader variability. This also applied to automatic categorization of the DAT-SPECT images based on the putamen SBR (1.78% discrepant cases between without versus with ASC). CONCLUSION: Given the large sample size, the current findings provide strong evidence against a relevant impact of ASC with uniform attenuation and simulation-based scatter correction on the clinical utility of DAT-SPECT to detect nigrostriatal degeneration in patients with clinically uncertain parkinsonian syndrome. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-023-06293-2.
format Online
Article
Text
id pubmed-10541531
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-105415312023-10-02 No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome Schiebler, Tassilo Apostolova, Ivayla Mathies, Franziska Lara Lange, Catharina Klutmann, Susanne Buchert, Ralph Eur J Nucl Med Mol Imaging Original Article PURPOSE: The benefit from attenuation and scatter correction (ASC) of dopamine transporter (DAT)-SPECT for the detection of nigrostriatal degeneration in clinical routine is still a matter of debate. The current study evaluated the impact of ASC on visual interpretation and semi-quantitative analysis of DAT-SPECT in a large patient sample. METHODS: One thousand seven hundred forty consecutive DAT-SPECT with (123)I-FP-CIT from clinical routine were included retrospectively. SPECT images were reconstructed iteratively without and with ASC. Attenuation correction was based on uniform attenuation maps, scatter correction on simulation. All SPECT images were categorized with respect to the presence versus the absence of Parkinson-typical reduction of striatal (123)I-FP-CIT uptake by three independent readers. Image reading was performed twice to assess intra-reader variability. The specific (123)I-FP-CIT binding ratio (SBR) was used for automatic categorization, separately with and without ASC. RESULTS: The mean proportion of cases with discrepant categorization by the same reader between the two reading sessions was practically the same without and with ASC, about 2.2%. The proportion of DAT-SPECT with discrepant categorization without versus with ASC by the same reader was 1.66% ± 0.50% (1.09–1.95%), not exceeding the benchmark of 2.2% from intra-reader variability. This also applied to automatic categorization of the DAT-SPECT images based on the putamen SBR (1.78% discrepant cases between without versus with ASC). CONCLUSION: Given the large sample size, the current findings provide strong evidence against a relevant impact of ASC with uniform attenuation and simulation-based scatter correction on the clinical utility of DAT-SPECT to detect nigrostriatal degeneration in patients with clinically uncertain parkinsonian syndrome. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00259-023-06293-2. Springer Berlin Heidelberg 2023-06-17 2023 /pmc/articles/PMC10541531/ /pubmed/37328621 http://dx.doi.org/10.1007/s00259-023-06293-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Schiebler, Tassilo
Apostolova, Ivayla
Mathies, Franziska Lara
Lange, Catharina
Klutmann, Susanne
Buchert, Ralph
No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome
title No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome
title_full No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome
title_fullStr No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome
title_full_unstemmed No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome
title_short No impact of attenuation and scatter correction on the interpretation of dopamine transporter SPECT in patients with clinically uncertain parkinsonian syndrome
title_sort no impact of attenuation and scatter correction on the interpretation of dopamine transporter spect in patients with clinically uncertain parkinsonian syndrome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541531/
https://www.ncbi.nlm.nih.gov/pubmed/37328621
http://dx.doi.org/10.1007/s00259-023-06293-2
work_keys_str_mv AT schieblertassilo noimpactofattenuationandscattercorrectionontheinterpretationofdopaminetransporterspectinpatientswithclinicallyuncertainparkinsoniansyndrome
AT apostolovaivayla noimpactofattenuationandscattercorrectionontheinterpretationofdopaminetransporterspectinpatientswithclinicallyuncertainparkinsoniansyndrome
AT mathiesfranziskalara noimpactofattenuationandscattercorrectionontheinterpretationofdopaminetransporterspectinpatientswithclinicallyuncertainparkinsoniansyndrome
AT langecatharina noimpactofattenuationandscattercorrectionontheinterpretationofdopaminetransporterspectinpatientswithclinicallyuncertainparkinsoniansyndrome
AT klutmannsusanne noimpactofattenuationandscattercorrectionontheinterpretationofdopaminetransporterspectinpatientswithclinicallyuncertainparkinsoniansyndrome
AT buchertralph noimpactofattenuationandscattercorrectionontheinterpretationofdopaminetransporterspectinpatientswithclinicallyuncertainparkinsoniansyndrome